Catalent | CTLT - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Agilent USD 37.86B 3.64B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Centene USD 20.23B 2.7B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Cigna USD 73.52B 3.42B 2025-12
Danaher USD 140.45B 11.98B 2026-04
Dentsply International USD 2.28B 251M 2025-12
Elevance Health USD 76.12B 11.81B 2026-04
Eli Lilly USD 1.02T 293.84B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Humana USD 30.81B 485M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Intuitive Surgical USD 159.96B 3.77B 2026-04
IQVIA Holdings USD 29.18B 9.2B 2026-04
J&J USD 561.65B 17.5B 2026-04
Laboratory Of America USD 20.8B 3.03B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
McKesson USD 101.25B 5.15B 2025-12
Merck EUR 53.3B 5.72B 2025-12
Merck USD 261.26B 51.62B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Quest Diagnostics USD 22.89B 1.19B 2026-04
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
UnitedHealth USD 319B 73.39B 2026-04
Veradigm USD 525M 621M 2026-03
Waters USD 22.61B 5.25B 2025-12
West Pharmaceutical Services USD 22.67B 4.61B 2026-04